[Type IIA juxtafoveal telangiectasis associated with subretinal neovascularisation].
This is a case report of a type IIA juxtafoveal telangiectasia complicated with secondary subretinal neovascularization in one eye and treated with VEGF inhibitor that succeeded in at least temporary inactivating the neovascular membrane.
Stinghe
Alina L
AL
Department of Ophthalmology, Southampton General Hospital.
D000368:Aged; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D005584:Fovea Centralis; D006801:Humans; D008297:Male; D015861:Retinal Neovascularization / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D013684:Telangiectasis / Q000150:complications* / Q000188:drug therapy / Q000473:pathology*; D016896:Treatment Outcome
D020533:Angiogenesis Inhibitors